Barnard College settles suit brought by Jewish students, agreeing not to meet with anti-Israel group
The Manhattan college, an all-women's affiliate of Columbia University, will also establish a new Title VI coordinator to enforce against claims of discrimination. Beginning next semester, all students and staff will receive a message conveying a 'zero tolerance' policy for harassment of Jewish and Israeli students.
The settlement was announced in a joint statement by Barnard and lawyers for two Jewish advocacy groups, Students Against Antisemitism and StandWithUs Center for Legal Justice, who brought the lawsuit last February on behalf of some Jewish and Israeli students.
In the statement, Barnard's president, Laura Ann Rosenbury, said the agreement 'reflects our ongoing commitment to maintaining a campus that is safe, welcoming, and inclusive for all members of our community.'
The terms of the deal also drew immediate pushback from some students and faculty, who accused the university of capitulating to a legal strategy aimed at stifling legitimate pro-Palestinian activism on campus.
'This settlement appears to equate criticism of Israel with antisemitism,' said Nara Milanich, a Barnard history professor who is Jewish. 'That is a problem for critical thought and academic freedom.'
As part of the agreement, the college will adopt contentious federal guidance to 'consider' the International Holocaust Remembrance Alliance's definition of antisemitism and its examples, which include certain critiques of Israel.
A newly-appointed Title VI coordinator will oversee compliance with the policy and produce an annual report on antisemitism for university leaders.
Additionally, the university's leaders agreed not to recognize, meet or negotiate with Columbia University Apartheid Divest, the coalition behind last spring's student encampments. The group has called on both Columbia and Barnard to sever ties with companies that do business with Israel.
As part of the deal, the university will also affirm that its endowment will not be used for expressing political positions, including 'taking actions for the purpose of penalizing the government of a country or the commercial/financial activity within that country.'
The agreement follows a federal lawsuit brought last February that accused Barnard and Columbia of allowing Jewish and Israeli students to be 'bombarded' by antisemitism during protests that erupted against Israel's military campaign in Gaza.
The litigation against Columbia remains ongoing — though the university has already agreed to revamp its policies around protests, among other concessions made under threat from the Trump administration.
New York University and Harvard University have entered into their own legal settlements following lawsuits focused on antisemitism.
In the lawsuit against Columbia and Barnard, Jewish and Israeli students said they were subject to unchecked harassment during protests by 'mobs of pro-Hamas students and faculty.' Those who participated in the protests, including many Jewish students, have strongly disputed that characterization.
The lawsuit also claimed that students who served in Israel's military were singled out, with some left 'overwhelmed and unable to concentrate in class' after encountering signs accusing Israel of committing genocide and social media posts from fellow students.
Starting next semester, students will be reminded that they can be subject to discipline for off-campus conduct, including social media posts.
Barnard will also restrict where, when and how students can protest. And the university will ban face masks at demonstration used to 'intimidate or interfere with the enforcement' of school policies.
'Barnard's commitment to take meaningful actions to combat antisemitism demonstrates its leadership in the fight against antisemitism and upholding the rights of Jewish and Israeli students,' said Marc Kasowitz, an attorney for the plaintiffs. 'I encourage other colleges and universities to do the right thing and follow Barnard's lead.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures drift as Wall Street braces for July inflation report
US stock futures wavered around the flatline on Tuesday as Wall Street braced for July's inflation report and President Trump revealed his pick to head the Bureau of Labor Statistics. Futures attached to the Dow Jones Industrial Average (YM=F), the benchmark S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) all fell below the flatline. Intel (INTC) stock jumped more than 2% in premarket trading on Tuesday after CEO Lip-Bu Tan met with President Trump, who had called for Tan's resignation last week. After the meeting, Trump posted to Truth Social saying that he had met with Tan along with Secretary of Commerce Howard Lutnick and Secretary of the Treasury Scott Bessent. "The meeting was a very interesting one," the president wrote, adding, "His success and rise is an amazing story." On Tuesday, reports said China urged local firms not to use Nvidia H20 chips, complicating Trump's bid to turn those sales into a US windfall. After the bell on Monday, Trump announced that he nominated E.J. Antoni, chief economist at the conservative Heritage Foundation, to lead the BLS. "E.J. will ensure that the Numbers released are HONEST and ACCURATE," the president said on Truth Social. Trump fired Erika McEntarfer as commissioner of the BLS earlier this month following the release of the July jobs report, which contained "larger than normal" revisions to data and revealed fewer jobs than previously thought had been added to the economy. Trump said, without providing evidence, that McEntarfer had been acting politically and her numbers "were wrong." During day trading, stocks slumped even as Trump reportedly granted another 90-day pause on the most punishing tariffs on China as the two countries work toward a trade deal. Read more: The latest on Trump's tariffs Wall Street is preparing for the release of July's Consumer Price Index (CPI) report on Tuesday morning. Analysts expect it to show that prices increased as Trump's tariffs kicked in. A hot inflation report could put the Federal Reserve in a tight spot as it navigates rising prices amid recent signs of a weakening labor market. In the background, anticipation over the possibility of a September interest rate cut continues to grow. Investors will get two more pulse checks on the state of the economy later this week, with the release of the Producer Price Index on Thursday and retail sales data on Friday. Cannabis stocks soar as President Trump considers reclassifying marijuana Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Intel is still a disaster Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Japan's Nikkei hits record high on tariff relief, tech rally The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here. Cannabis stocks soar as President Trump considers reclassifying marijuana Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Tilray (TLRY) stock rose another 10% in premarket trading on Tuesday after soaring 41% on Monday amid speculation that President Trump may move to reclassify marijuana as a less dangerous drug. The Canadian cannabis company traded hands at over $1 per share for the first time since February. Despite a 60% gain in the past month, however, shares are still off by 30% for the year. Other cannabis stocks saw a major lift as well. Trulieve (TCNNF) gained 38% on Monday, Curaleaf (CURLF) was up 35%, Green Thumb Industries (GTBIF) added 19%, Aurora (ACB) increased 16%, and Canopy Growth (CGC) surged 26%. On Friday, the Wall Street Journal reported that Trump told donors at a New Jersey fundraiser he was considering making marijuana a Schedule III drug, which would ease restrictions on the substance. Trump said he will make a final decision in the coming weeks. "We're looking at reclassification and we'll make a determination over the next — I would say over the next few weeks, and that determination hopefully will be the right one," Trump said. "It's a very complicated subject." Intel is still a disaster Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Intel (INTC) is rallying premarket as Trump walked back his apparent hate for the company's CEO, Lip-Bu Tan, after meeting on Monday. Don't be fooled by the price action, however. This isn't the case like Apple (AAPL), where CEO Tim Cook kisses Trump's butt and the company is exempt from various tariffs. Intel is a fundamental disaster right now. People in the industry I talk to are unsure if the company will ever come back to a state of health, given 1) how fast AI chip development is occurring, and 2) how far behind Nvidia and AMD Intel is. Intel's statement on the meeting: "Earlier today, Mr. Tan had the honor of meeting with President Trump for a candid and constructive discussion on Intel's commitment to strengthening U.S. technology and manufacturing leadership. We appreciate the President's strong leadership to advance these critical priorities and look forward to working closely with him and his Administration as we restore this great American company." Japan's Nikkei hits record high on tariff relief, tech rally The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here. The Nikkei 225 (^N225) hit a record high Tuesday as easing US tariff fears boosted optimism, led by tech stocks and tariff relief. Bloomberg News reports: Read more here.


CNN
25 minutes ago
- CNN
Mayor fires back at Trump after he calls Baltimore ‘too far gone'
Baltimore Mayor Brandon Scott (D) responded to President Donald Trump's criticism about violence in his city by highlighting historic drops in violent crime. President Trump warned other major cities about federal intervention after he placed the Washington, DC, police department under federal control and deployed the National Guard.


Fox News
25 minutes ago
- Fox News
Trump targets cartels with military action: 'It's about time!'
Former Acting DEA Administrator Derek Maltz joins 'Fox & Friends' to warn of a new synthetic opioid from China and discuss President Donald Trump's order to use military force against cartels allegedly trafficking fentanyl across the border.